Biosimilars available from Cencora
We believe in the promise of biosimilars to deliver cost savings across healthcare and we have access to every approved biosimilars launched in the United States. We also understand the potential hurdles these unique products will face. That's why we offer solutions for increasing access to and confidence in these emerging therapies.
To date, there have been 69 approvals and 49 launches* in the U.S. biosimilar market. Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options. With increased biosimilar adoption, we can improve medication access and affordability, and better support the patients we serve.
Below you will find the biosimilars available through Cencora in the US.
| Biosimilar | Reference product | Patient support services | Drug information |
|---|---|---|---|
| Tyenne (tocilizumab-aazg) |
Actemra® |
https://www.tyennehcp.com/get-to-know-tyenne |
Read more |
| Tofidence (tocilizumab-bavi) |
Actemra® |
https://www.tofidencehcp.com/ |
Read more |
| Mvasi (bevacizumab-awwb) | Avastin® | Amgen Assist 360TM | Read more |
| Zirabev (bevacizumab-bvzr) | Avastin® | Pfizer Oncology TogetherTM | Read more |
| Alymsys (bevacizumab-maly) | Avastin® | Amneal PATHways® | Read more |
| Vegzelma (bevacizumab-adcd) | Avastin® | Vegzelma patient support | Read more |
| Retacrit (epoetin alfa-epbx) | Epogen/Procrit® | Pfizer enCompass® | Read more |
| Pavblu (aflibercept-ayyh) |
Eylea |
https://www.pavblu.com/ |
Read more |
| Kanjinti (trastuzumab-anns) | Herceptin® | Amgen Assist 360TM | Read more |
| Ogiviri (trastuzumab-dkst) | Herceptin® | Viatris Advocate® | Read more |
| Ontruzant (trastuzumab-dttb) | Herceptin® | Organon Access Program | Read more |
| Trazimera (trastuzumab-qyyp) | Herceptin® | Pfizer Oncology TogetherTM | Read more |
| Herzuma (trastuzumab-pkrb) | Herceptin® | Teva Shared Solutions® | Read more |
| Hercessi (trastuzumab-strf) | Herceptin® | https://www.hercessihcp.com/patient-support/ |
Read more |
| Amjevita (adalimumab-atto) | Humira® | AMJEVITA SupportPlus Co-Pay program | Read more |
| Cyltezo (adalimumab-adbm) | Humira® | BI Cares Patient Assistance Program | Read more |
| Hadlima (adalimumab-bwwd) | Humira® | Hadlima patient support | Read more |
| Hulio (adalimumab-fkjp) | Humira® | Hulio360 | Read more |
| Hyrimoz (adalimumab-adaz) | Humira® | Sandoz One Source | Read more |
| Idacio (adalimumab-aacf) | Humira® | Kabicare | Read more |
| Yuflyma (adalimumab-aaty) | Humira® | Celltrion Connect | Read more |
| Yusimry (adalimumab-aqvh) | Humira® | Patient Support Services | Read more |
| Abrilada (adalimumab-afzb) | Humira® | Pfizer enCompass® | Read more |
| Simlandi (adalimumab-ryvk) |
Humira® | https://www.simlandi.com/ | Read more |
| Rezvoglar (insulin glargine-aglr) | Lantus® | Rezvoglar support information | Read more |
| Semglee (insulin glargine-yfgn) | Lantus® | Semglee Savings and Support | Read more |
| Byooviz (ranibizumab-nuna) | Lucentis® | Biogen Biosimilar Support Services | Read more |
| Cimerli (ranibizumab-eqrn) | Lucentis® | Cimerli SolutionsTM | Read more |
| Fulphila (pegfilgrastim-jmdb) | Neulasta® | Viatris Advocate® | Read more |
| Fylnetra (pegfilgrastim-pbbk) | Neulasta® | Amneal PATHways® Patient Support Program | Read more |
| Udenyca (pegfilgrastim-cbqv) | Neulasta® | Coherus SolutionsTM | Read more |
| Ziextenzo (pegfilgrastim-bmez | Neulasta® | Sandoz One Source | Read more |
| Nyvepria (pegfilgrastim-apgf) | Neulasta® | Pfizer Oncology TogetherTM | Read more |
| Stimufend (pegfilgrastim-fpgk) | Neulasta® | KabiCare | Read more |
| Nivestym (filgrastim-aafi) | Neupogen® | Pfizer Oncology TogetherTM | Read more |
| Releuko (filgrastim-ayow) | Neupogen® | Amneal PATHways® | Read more |
| Zarxio (filgrastim-sndz) | Neupogen® | Sandoz One Source | Read more |
| Avsola (infliximab-axxq) | Remicade® | Amgen Assist® | Read more |
| Inflectra (infliximab-dyyb) | Remicade® | Pfizer enCompass® | Read more |
| Renflexis(infliximab-abda) | Remicade® | Organon Access Program | Read more |
| Riabni (rituximab-arrx) | Rituxan® | Amgen Assist 360® | Read more |
| Ruxience (rituximab-pvvr) | Rituxan® | Pfizer Oncology TogetherTM | Read more |
| Truxima (rituximab-abbs) | Rituxan® | Teva Shared Solutions® | Read more |
| Wezlana (ustekinumab-auub) |
Stelara |
https://www.wezlana.com/ |
Read more |
| Selarsdi (ustekinumab-aekn) |
Stelara |
https://www.selarsdi.com/savings-and-support/ |
Read more |
| Pyzchiva (ustekinumab-ttwe) |
Stelara |
https://sandoz-onesource.com/pyzchiva/ |
Read more |
| Otulfi (ustekinumab-aauz) |
Stelara |
https://www.kabicare.us/ |
Read more |
| Steqeyma (ustekinumab-stba) |
Stelara | https://steqeyma.com/support/ |
Read more |
| Yesintek (ustekinumab-kfce) |
Stelara |
https://yesintek.com/savings-and-support/ |
Read more |
Related resources
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.